ZnT-8 Inhibitors

The class of ZnT-8 inhibitors, in the context of indirect inhibition, includes a variety of compounds that influence zinc homeostasis, insulin synthesis, and secretion in pancreatic beta cells. ZnT-8 plays a critical role in the transport of zinc into insulin granules, which is essential for the proper storage and function of insulin. Compounds like Chelerythrine, Diazoxide, Nifedipine, and Verapamil, which modulate the activity of ion channels and enzymes in beta cells, can indirectly impact ZnT-8 by altering insulin secretion. The modulation of insulin secretion and the associated cellular processes can influence the demand for zinc transport and thus the activity of ZnT-8.

In addition, agents such as Phlorizin, Alloxan, Streptozotocin, and Glibenclamide affect glucose metabolism and beta cell function. These compounds, by influencing the cellular environment and metabolic state of beta cells, can indirectly modulate the activity of ZnT-8. Nicotinamide, known for its protective effects on beta cells, and Exendin-4, a GLP-1 receptor agonist, also contribute to this class by affecting insulin secretion pathways. Metformin, a widely used antidiabetic drug, can indirectly influence ZnT-8 through its actions on glucose metabolism. Additionally, zinc chelators like TPEN, by affecting zinc availability, can indirectly impact the function of ZnT-8, as zinc homeostasis is crucial for the transporter's activity.